ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 292 filers reported holding ICU MED INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $133,885,655 | +26.8% | 1,124,995 | +89.9% | 0.01% | +33.3% |
| Q2 2023 | $105,579,760 | +85.1% | 592,512 | +71.3% | 0.01% | +200.0% |
| Q1 2023 | $57,052,736 | +50569.0% | 345,858 | +48271.7% | 0.00% | – |
| Q4 2022 | $112,599 | -29.6% | 715 | -33.3% | 0.00% | – |
| Q3 2022 | $160,000 | -16.7% | 1,072 | -7.8% | 0.00% | – |
| Q2 2022 | $192,000 | -44.0% | 1,163 | -24.5% | 0.00% | – |
| Q1 2022 | $343,000 | +203.5% | 1,540 | +223.5% | 0.00% | – |
| Q4 2021 | $113,000 | -21.5% | 476 | -23.0% | 0.00% | – |
| Q3 2021 | $144,000 | +0.7% | 618 | -11.2% | 0.00% | – |
| Q2 2021 | $143,000 | 0.0% | 696 | -0.3% | 0.00% | – |
| Q1 2021 | $143,000 | -56.1% | 698 | -54.0% | 0.00% | – |
| Q4 2020 | $326,000 | +17.7% | 1,519 | +0.1% | 0.00% | – |
| Q3 2020 | $277,000 | -2.1% | 1,518 | -1.2% | 0.00% | – |
| Q2 2020 | $283,000 | -14.0% | 1,536 | -5.8% | 0.00% | – |
| Q1 2020 | $329,000 | +6.8% | 1,631 | -1.0% | 0.00% | – |
| Q4 2019 | $308,000 | -99.5% | 1,647 | -99.6% | 0.00% | -100.0% |
| Q3 2019 | $59,316,000 | -36.6% | 371,653 | +0.0% | 0.01% | -36.4% |
| Q2 2019 | $93,623,000 | -6.4% | 371,652 | -11.0% | 0.01% | -8.3% |
| Q1 2019 | $99,979,000 | +4.2% | 417,742 | -0.0% | 0.01% | -7.7% |
| Q4 2018 | $95,937,000 | +55.2% | 417,787 | +91.1% | 0.01% | +85.7% |
| Q3 2018 | $61,810,000 | +80.5% | 218,602 | +87.4% | 0.01% | +75.0% |
| Q2 2018 | $34,249,000 | +18.0% | 116,630 | +1.4% | 0.00% | +33.3% |
| Q1 2018 | $29,025,000 | +21.0% | 114,996 | +3.5% | 0.00% | 0.0% |
| Q4 2017 | $23,989,000 | +131.4% | 111,058 | +57.8% | 0.00% | +200.0% |
| Q4 2016 | $10,367,000 | -83.8% | 70,359 | -86.1% | 0.00% | -87.5% |
| Q3 2016 | $63,799,000 | -6.1% | 504,818 | -16.3% | 0.01% | -11.1% |
| Q2 2016 | $67,967,000 | +20.3% | 602,812 | +11.0% | 0.01% | +12.5% |
| Q1 2016 | $56,509,000 | -15.1% | 542,836 | -8.0% | 0.01% | -11.1% |
| Q4 2015 | $66,531,000 | -9.8% | 589,922 | -12.4% | 0.01% | -10.0% |
| Q3 2015 | $73,736,000 | +188.1% | 673,390 | +151.7% | 0.01% | +233.3% |
| Q2 2015 | $25,592,000 | +128.2% | 267,531 | +122.2% | 0.00% | +200.0% |
| Q1 2015 | $11,214,000 | +52.1% | 120,397 | +33.8% | 0.00% | 0.0% |
| Q4 2014 | $7,372,000 | -74.8% | 90,008 | -80.4% | 0.00% | -75.0% |
| Q4 2013 | $29,217,000 | +20.9% | 458,600 | +28.9% | 0.00% | 0.0% |
| Q3 2013 | $24,176,000 | -5.7% | 355,900 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $25,646,000 | – | 355,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |